Cite
HARVARD Citation
Papathanasiou, T. et al. (2020). Impact of dose‐escalation schemes and drug discontinuation on weight loss outcomes with liraglutide 3.0 mg: A model‐based approach. Diabetes, obesity & metabolism. 22 (6), pp. 969-977. [Online].